Skip to Content
Find More Like This
Return to Search

EGVII endoglucanase and nucleic acids encoding the same

United States Patent

February 14, 2012
View the Complete Patent at the US Patent & Trademark Office
National Renewable Energy Laboratory - Visit the NREL Technology Transfer Website
The present invention provides a novel endoglucanase nucleic acid sequence, designated egl7, and the corresponding EGVII amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVII, recombinant EGVII proteins and methods for producing the same.
Dunn-Coleman; Nigel (Los Gatos, CA), Goedegebuur; Frits (Vlaardingen, NL), Ward; Michael (San Francisco, CA), Yao; Jian (Sunnyvale, CA)
Danisco US Inc. (Palo Alto, CA)
12/ 250,316
October 13, 2008
GOVERNMENT SUPPORT Portions of this work were funded by Subcontract No. ZCO-30017-01 with the National Renewable Energy Laboratory under Prime Contract No. DE-AC36-99GO10337 with the U.S. Department of Energy. Accordingly, the United States Government may have certain rights in this invention. CROSS REFERENCE This application is a continuation of U.S. application Ser. No. 11/329,498 filed Jan. 10, 2006, now U.S. Pat. No. 7,449,319 which is a division of U.S. application Ser. No. 10/028,244 filed on Dec. 18, 2001, now U.S. Pat. No. 7,045,331, the teachings of which are incorporated by reference herein in their entirety.